immuno-oncologyeurope.com

Immuno Oncology Summit Europe

The Second Annual Immuno-Oncology Summit Europe 2017 in London, produced by Cambridge Healthtech Institute, provides attendees with a full week of updates on T cells and their receptors including chimeric antigen receptor (CAR-T) technology, bispecifics, preclinical models, and targets and lead selection. Immuno-Modulatory Approaches will look at advances in checkpoint inhibitors, agonistic receptor engagement, NK, macrophage and dendritic cell activation, Fc-engineering technologies, cytokine-based therapi

http://www.immuno-oncologyeurope.com/

OVERVIEW OF immuno-oncologyeurope.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

4

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR IMMUNO-ONCOLOGYEUROPE.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 3.9 out of 5 with 16 reviews

5 star

5

4 star

6

3 star

4

2 star

0

1 star

1

Hey there! Start your review of immuno-oncologyeurope.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

1 seconds

FAVICON PREVIEW

16x16

CONTACTS AT IMMUNO-ONCOLOGYEUROPE.COM

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

PAGES IN
THIS WEBSITE

4

SSL

EXTERNAL LINKS

3

SITE IP

205.174.26.165

LOAD TIME

1.016 sec

SCORE

6.2

PAGE TITLE

Immuno Oncology Summit Europe | immuno-oncologyeurope.com Reviews

<META> DESCRIPTION

The Second Annual Immuno-Oncology Summit Europe 2017 in London, produced by Cambridge Healthtech Institute, provides attendees with a full week of updates on T cells and their receptors including chimeric antigen receptor (CAR-T) technology, bispecifics, preclinical models, and targets and lead selection. Immuno-Modulatory Approaches will look at advances in checkpoint inhibitors, agonistic receptor engagement, NK, macrophage and dendritic cell activation, Fc-engineering technologies, cytokine-based therapi

<META> KEYWORDS

1 Immuno-Oncology Summit; Immuno-Oncology Conference; Immunotherapy; T Cell Therapy; Immuno-Modulatory; Bispecifics; cancer research london; cancer therapy conference

2

3 coupons

4 reviews

5 scam

6 fraud

7 hoax

8 genuine

9 deals

10 traffic

CONTENT

Page content here

KEYWORDS ON PAGE

agenda,programs,short courses,speakers,speaker biographies,participants,sponsor/exhibit,current sponsors,current exhibitors/floorplan,sponsorship opportunities,exhibitor prospectus,exhibit contract,exhibitor kit,lead generation opportunities,downloads

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Immuno Oncology Summit Europe | immuno-oncologyeurope.com Reviews

https://immuno-oncologyeurope.com

The Second Annual Immuno-Oncology Summit Europe 2017 in London, produced by Cambridge Healthtech Institute, provides attendees with a full week of updates on T cells and their receptors including chimeric antigen receptor (CAR-T) technology, bispecifics, preclinical models, and targets and lead selection. Immuno-Modulatory Approaches will look at advances in checkpoint inhibitors, agonistic receptor engagement, NK, macrophage and dendritic cell activation, Fc-engineering technologies, cytokine-based therapi

INTERNAL PAGES

immuno-oncologyeurope.com

1

Immuno Oncology Summit Europe

http://www.immuno-oncologyeurope.com/imxe-homepage.aspx

Final Agenda Now Available. Sponsorship and Exhibit Opportunities Available. Register Now for Maximum Savings. 160; . Tuesday, 21 March, 18:30-21:30. New Directions in Cancer Immunotherapy. CAR T and TCR Manufacturing Challenges to Anticipate and Overcome. Roy D Baynes, M.D., Ph.D. Senior Vice President and Head, Global Clinical Development, CMO, Merck Sharp and Dohme. Zelig Eshhar, Ph.D. Chair, Cancer Immunotherapy, Research and Development, Sourasky Medical Center, Tel Aviv. Dario Neri, Ph.D. I believ...

2

Immunomodulatory Approaches

http://www.immuno-oncologyeurope.com/immunomodulatory-therapy

Day 1 Day 2. Tuesday, 21 March. Catherine Sabatos-Peyton, Ph.D., Senior Investigator II, Exploratory Immuno-Oncology, Novartis Institutes for BioMedical Research (NIBR). CHECKPOINT INHIBITORS AND MODES OF ACTION. Multiple Checkpoint Blockade with Bispecific Antibodies. John Desjarlais, Ph.D., CSO, Xencor, Inc. We have optimised an Fc-containing bispecific antibody platform with high stability, efficient production, and antibody-like pharmacokinetics. We will present application of the platform to dua...

3

Combination Immunotherapy

http://www.immuno-oncologyeurope.com/combination-immunotherapy

The future of immuno-oncology drug development is positioned in combination therapies, where immunotherapy modalities are tested in rational combinations with other immunotherapies or targeted therapies for synergistic effects. Combination immunotherapy promises to deliver long-term survival benefits that may be unavailable with current approaches. The Inaugural. Meeting, part of the Second Annual. Day 1 Day 2. Thursday, 23 March. Registration and Morning Coffee. Christian Ottensmeier, M.D., Ph&#...Cance...

4

Novel Approaches for Cancer

http://www.immuno-oncologyeurope.com/novel-cancer-therapy

Case studies include identification and validation of suitable targets, measures to overcome cross reactivity; engineering for enhancement of efficacy; preclinical models, design of clinical studies and clinical data, manufacturing and supply of T cell products, and targeting of solid tumours. Day 1 Day 2. Monday, 20 March. Conference Registration and Morning Coffee. David Gilham, Ph.D., Vice President, Research and Development, Celyad S.A. CAR-T Cells: From Basic Research to Cancer Treatment. We have de...

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL PAGES IN THIS WEBSITE

4

LINKS TO THIS WEBSITE

healthtech.com

CHI Conferences - Your Life Science Network

http://www.healthtech.com/Conferences/Updates.aspx

Displaying page 1 of 13, items 1 to 20 of 250. Call for papers posted for PEGS China. March 28 30, 2017. Preliminary Agenda Posted for Molecular Med Tri-Con. February 19-24, 2017. Call for papers posted for Oligonucleotide and Peptide Therapeutics Boston. March 27 - 29, 2017. Final Agenda posted for PepTalk-The Protein Science Week. 160;January 9-13, 2017. Final Agenda posted for Re-Entering Antibacterial Discovery and Development Summit. 160;December 7-9, 2016. 160;December 7-9, 2016. March 20-24, 2017.

UPGRADE TO PREMIUM TO VIEW 2 MORE

TOTAL LINKS TO THIS WEBSITE

3

SOCIAL ENGAGEMENT

HealthtechConferences

CHI_Healthtech

OTHER SITES

immuno-m12.wikispaces.com

immuno-m12 - Wiki Home

Skip to main content. Get your Wikispaces Classroom now:. The easiest way to manage your class. Roadmap to Immunology Chalkboard. Welcome to the Official Wikispace for the Kavli Institute for Theoretical Physics program. Quantitative Immunology: Experiments Meet Modeling. Nov 26, 2012 - Dec 20, 2012. Grégoire Altan-Bonnet, Phil Hodgkin, Alan Perelson, Anton Zilman. Arup Chakraborty, Rob de Boer, Ron Germain, Ruy Ribeiro. There is practice wikispace. Help on how to format text. Turn off "Getting Started".

immuno-onc.atpointofcare.com

@ Point of Care

immuno-onco.com

Ce domaine a été enregistré par Online.net

Ce domaine a été enregistré. Online est l'un des acteurs majeurs de l'hébergement en France. Créée en 2000 en même temps que le service d'accès à internet Free, nous sommes une filiale à 100% du groupe Iliad, focalisée sur les services d'hébergement Internet destinés aux webmasters et professionnels de l'internet. Êtes-vous le propriétaire de ce nom de domaine? Trouvez une solution d'hébergement pour votre domaine! Découvrez nos offres d'hébergements. Et de serveurs dédiés. Hébergez votre site web.

immuno-oncologiesymposium.nl

Multidisciplinair Immuno-Oncologie Symposium

T 31(0)73 690 14 15. F 31(0)73 690 14 17. Dinsdag 13 september 2016. 2e Multidisciplinair Immuno-Oncologie Symposium. Gezien het succes van afgelopen editie, is de programmacommissie trots om u te kunnen meedelen dat er ook dit jaar een Multidisciplinair Immuno- Oncologie Symposium georganiseerd wordt! Er 2 parallel sessies gepland staan met elk een eigen aandachtsgebied, te weten de medische oncologie en pulmonale oncologie. De bijeenkomst vindt plaats in de Prodentfabriek in Amersfoort. Deze locati...

immuno-oncology.org

7èmes Journées d'Immunologie & Immunothérapie des Cancers

9-11 décembre 2013 à Dijon. Ces journées sont biennales, les conférences données en français durent 30 min suivies de 15 min de discussion. Elles sont organisées par Jean-François Jeannin et le laboratoire d'immunologie et immunothérapie des cancers de l'EPHE (EA 7269 associée à l'INSERM UMR 866) assistés du service de formation continue de l'EPHE. Journées d'immunologie et immunothérapie des cancers. 9-11 décembre 2013, Dijon. Salle du conseil de la faculté des sciences Mirande.

immuno-oncologyeurope.com

Immuno Oncology Summit Europe

Final Agenda Now Available. Sponsorship and Exhibit Opportunities Available. Register Now for Maximum Savings. 160; . Tuesday, 21 March, 18:30-21:30. New Directions in Cancer Immunotherapy. CAR T and TCR Manufacturing Challenges to Anticipate and Overcome. Roy D Baynes, M.D., Ph.D. Senior Vice President and Head, Global Clinical Development, CMO, Merck Sharp and Dohme. Zelig Eshhar, Ph.D. Chair, Cancer Immunotherapy, Research and Development, Sourasky Medical Center, Tel Aviv. Dario Neri, Ph.D. I believ...

immuno-oncologynews.com

Immuno-Oncology News - The Web's Daily Resource for Immuno-Oncology News

Cancer Immunotherapy Based on Engineered Immune Cells as a Promising Approach Against Myeloma. Potential New Immunotherapy For Melanoma. Enhancing Anti-Tumoral Immunity by Inhibiting Specific Enzyme. Adoptive Cell ImmunoTherapy (ACT) - Advancing Personalised Cancer Treatment. Immune Checkpoint Protein Blockade And Low Dose Entire Body Irradiation Identified As Myeloma Immunotherapy. Phase I Study Finds Nivolumab Beneficial In Hodgkin's Lymphoma Patients. Potential New Immunotherapy For Melanoma. Celsion ...

immuno-oncologysummit.com

Immuno Oncology Summit

JOIN US NEXT YEAR AT THE PREMIER ANNUAL IO EVENT. AUGUST 28-SEPTEMBER 1, 2017 SHERATON BOSTON HOTEL. Overall, this event provided a focused look at how researchers are applying new science and technology in the development of the next generation of effective and safe immunotherapies and the IO Summit Team is looking forward to 2017! If you have comments or suggestions for next year's program, please contact Samantha Drinkwater at 781-972-5461 or sdrinkwater@healthtech.com. Emerging Innate Immune Targets ...

immuno-onkologi.dk

Bristol-Myers Squibb immuno-onkologi

Derfor er I-O anderledes. Central T-Celleaktivering og hæmning. T-celle aktivering ved costimulatorisk signal. Perifer hæmning af T-celler. Hæmning og nedregulering af T-celler. I-O på tværs af cancerformer. Udforsk styrken ved immuno-onkologi. Bristol-Myers Squibb er dedikeret til forskning i immuno-onkologi. Bristol-Myers Squibb er førende globalt, når det gælder banebrydende forskning inden for immuno-onkologi (I-O). Se hvorfor I-O er anderledes. I-O på tværs af tumortyper. Lær mere om I-O.

immuno-onkologia.pl

Immuno-onkologia.pl - nowa strategia leczenia nowotworów

Nowotwory głowy i szyi. Nowotwory głowy i szyi. Leki i cząsteczki immunoonkologiczne. Na czym polega immunoterapia raka? Co to jest immunoonkologia? Jak działa nasz układ immunologiczny? Szlaki punktów kontroli układu odpornościowego: PD-1, CTLA-4. Przegląd prasy i aktualnych publikacji poświęconych immunoterapii nowotworów. Best of WCLC – 17th World Conference on Lung Cancer. Eksperci: immunoterapia skuteczna w niedrobnokomórkowym raku płuca. Immunoterapia nieoperacyjnego, zaawansowanego raka żołądka.

immuno-onkoloji.org

İmmuno Onkoloji Derneği

1 İmmuno-Onkoloji Kongresi'nden Yansımalar. Görsel Basın ) ). Yazılı Basın ) ). 2015 İmmüno - Onkoloji Derneği. Bu site BMS'in koşulsuz eğitim katkılarıyla hazırlanmıştır.